Wutah dodolan YoY sajrone rolas wulan kepungkur: BioAge Labs, Inc (BIOA)

Logo grafis BioAge Labs, Inc (BIOA)

Is it worth investing in BioAge Labs, Inc. (BIOA), given the geopolitical risks and the disruption of biomaterial logistics? The year-over-year dynamics of core revenue over a rolling 12-month period provide the answer, where the value 45.80 captures the metric level. Growth potential is driven by the success of azelaprag in treating obesity, although the expected results of the Phase II trials for the oral drug are already priced in.

Wutah dodolan YoY sajrone rolas wulan kepungkur: BioAge Labs Inc. (BIOA) kanggo 23.11.2025 - 18.11.2026

BioAge (BIOA) - rincian metrik lan laporan keuangan

- nilai pasar lan prakiraan target analis:
- indikator kapitalisasi bursa perusahaan:
Ringkesan analitik perusahaan:BIOA BioAge Labs, Inc
Produk seri bioagelabs.com

BioAge Labs, Inc. (BIOA) focuses on developing innovative drugs to combat aging and metabolic pathologies by leveraging a high-tech analytical platform. The year-over-year sales growth trajectory over a rolling year transforms sporadic reports into a continuous data stream, allowing investors to filter out market noise and assess the actual dynamics of business scaling, which serves as the foundation for determining the sustainability of the stock's market value.

Pesaing BioAge Labs, Inc. (BIOA)

Ascendis (ASND) - Wutah pendapatan taun lumaku|MDGL - Wutah dodolan YoY sajrone rolas wulan kepungkur|CORT: Wutah dodolan YoY sajrone rolas wulan kepungkur|RYTM: Wutah dodolan YoY (TTM)|AKRO - Wutah pendapatan taunan sajrone rolas wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur Metsera Therapeutics|MoonLake Corp (MLTX) - Wutah pendapatan taunan sajrone rolas wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur crinetics.com (CRNX)|Wutah pendapatan YoY sajrone 12 wulan kepungkur newamsterdampharma.com NAMS|Wutah dodolan YoY sajrone rolas wulan kepungkur Soleno Therapeutics Inc SLNO|Wutah dodolan YoY (TTM) Amicus Therapeutics Inc FOLD|89bio Corp - Wutah dodolan YoY (TTM)|Tingkat wutah pendapatan YoY sajrone rolas wulan kepungkur Agios Pharmaceuticals Inc (AGIO)|Structure Therapeutics (GPCR) - Wutah dodolan YoY sajrone rolas wulan kepungkur|Wutah pendapatan YoY sajrone 12 wulan kepungkur MiMedx Group, Inc.|Wutah dodolan YoY sajrone rolas wulan kepungkur Rezolute Bio|Lexicon Pharmaceuticals, Inc. (LXRX) - Wutah pendapatan taunan sajrone rolas wulan kepungkur|Wutah dodolan YoY (TTM) MBX|Wutah pendapatan YoY sajrone 12 wulan kepungkur Altimmune, Inc. ALT|Wutah dodolan YoY (TTM) AARD (Aardvark Pharma)|Sagimet Biosciences Inc. (SGMT) - Wutah pendapatan taun lumaku|BMEA: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Dinamika pendapatan YoY sajrone rolas wulan kepungkur QNCX (Quince Therapeutics Inc)|GUTS (Fractyl) - Wutah pendapatan YoY sajrone 12 wulan kepungkur|vTv Therapeutics, Inc. - Dinamika pendapatan YoY sajrone rolas wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur Agape ATP Corp.|Wutah pendapatan YoY sajrone 12 wulan kepungkur Pluri (PLUR)|Wutah dodolan YoY (TTM) SYBX|Wutah pendapatan taunan sajrone rolas wulan kepungkur Lipocine Inc|Wutah dodolan YoY sajrone rolas wulan kepungkur Matinas BioPharma Holdings MTNB|Wutah pendapatan taunan sajrone rolas wulan kepungkur Spruce Biosciences (SPRB)|GLTO: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah dodolan taun lumaku CTCX|LUMO (Lumos Pharma) - Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah dodolan YoY sajrone 12 wulan kepungkur ONVO|RDUS (Radius Pharmaceuticals) - Wutah dodolan YoY (TTM)